Cucurbitacins: A Systematic Review of the Phytochemistry and Anticancer Activity

American Journal of Chinese Medicine

Volumn 43, Issue 7, 2015, Pages 1331-1350

  Cai, Yuee ^a   Fang, Xiefan ^b   He, Chengwei ^a   Li, Peng ^a   Xiao, Fei ^a,c   Wang, Yitao ^a   Chen, Meiwan ^a  

^a UNIVERSITY OF MACAU   (Macao)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

Anticancer; Cucurbitacins; Mechanism; Phytochemistry

Indexed keywords

ANTINEOPLASTIC AGENT; CUCURBITACIN; CUCURBITACIN B; CUCURBITACIN D; CUCURBITACIN E; CUCURBITACIN I; CUCURBITACIN IIA; CUCURBITACIN L GLUCOSIDE; CUCURBITACIN Q; CUCURBITACIN R; UNCLASSIFIED DRUG; DOCETAXEL; METHOTREXATE; TAXOID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTOPHAGY; CANCER GROWTH; CELL CYCLE ARREST; CELL DEATH; CELL INVASION; CELL MIGRATION; DRUG METABOLISM; HUMAN; INTRACELLULAR SIGNALING; METASTASIS; NONHUMAN; PHYTOCHEMISTRY; REVIEW; SYSTEMATIC REVIEW; TUMOR INVASION; ANIMAL; CELL CYCLE CHECKPOINT; CELL MOTION; CELL PROLIFERATION; CELL TRANSFORMATION; CHEMISTRY; CLASSIFICATION; COMBINATION DRUG THERAPY; CONFORMATION; DRUG EFFECTS; META ANALYSIS; NEOPLASMS; PATHOLOGY; PHYTOTHERAPY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CUCURBITACINS; DRUG THERAPY, COMBINATION; HUMANS; METHOTREXATE; MOLECULAR CONFORMATION; NEOPLASM INVASIVENESS; NEOPLASMS; PHYTOTHERAPY; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TAXOIDS;

EID: 84949723909     PISSN: 0192415X     EISSN: 17936853     Source Type: Journal    
DOI: 10.1142/S0192415X15500755     Document Type: Review

References (116)

1. Abbas, S., J.B. Vincourt, L. Habib, P. Netter, H. Greige-Gerges and J. Magdalou. The cucurbitacins E, D and I: Investigation of their cytotoxicity toward human chondrosarcoma SW 1353 cell line and their biotransformation in man liver. Toxicol. Lett. 216: 189-199, 2013.
2. Abdelwahab, S.I., L.E. Hassan, A.M. Abdul Majid, S.M. Yagi, S. Mohan, M.M. Elhassan Taha, S. Ahmad, C.S. Chuen, P. Narrima, M.M. Rais, S. Syam, B.A. Moharam and A.H. Hadi. Cucurbitacin L 2-O-β-glucoside demonstrates apoptogenesis in colon adenocarcinoma cells (HT-29): Involvement of reactive oxygen and nitrogen species regulation. Evid. Based. Complement. Alternat. Med. 2012: 490136, 2012.
3. Aggarwal, B.B., G. Sethi, K.S. Ahn, S.K. Sandur, M.K. Pandey, A.B. Kunnumakkara, B. Sung and H. Ichikawa. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: Modern target but ancient solution. Ann. N.Y. Acad. Sci. 1091: 151-169, 2006.
4. Ahmed, M.S. and F.T. Halaweish. Cucurbitacins: Potential candidates targeting mitogen-activated protein kinase pathway for treatment of melanoma. J. Enzym. Inhib. Med. Ch. 29: 162-167, 2014.
5. Arisawa, M., J.M. Pezzuto, A.D. Kinghorn, G.A. Cordell and N.R. Farnsworth. Plant anticancer agents. XXX: Cucurbitacins from ipomopsis-aggregata (Polemoniaceae). J. Pharm. Sci. 73: 411-413, 1984.
6. Balkema-Boomstra, A.G., S. Zijlstra, F.W.A. Verstappen, H. Inggamer, P.E. Mercke, M.A. Jongsma and H.J. Bouwmeester. Role of cucurbitacin C in resistance to spider mite (Tetranychus urticae) in cucumber (Cucumis sativus L.). J. Chem. Ecol. 29: 225-235, 2003.
7. Bartalis, J. and F.T. Halaweish. In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines. Bioirgan. Med. Chem. 19: 2757-2766, 2011.
8. Bean, M.F., M. Antoun, D. Abramson, C.J. Chang, J.L. McLaughlin and J.M. Cassady. Cucurbitacin B and isocucurbitacin B: Cytotoxic components of Helicteres isora. J. Nat. Prod. 48: 500, 1985.
9. Boykin, C., G. Zhang, Y.H. Chen, R.W. Zhang, X.E. Fan, W.M. Yang and Q. Lu. Cucurbitacin IIa: A novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting sur-vivin independent of JAK2/STAT3 phosphorylation. Brit. J. Cancer. 104: 781-789, 2011.
10. Chan, K.T., F.Y. Meng, Q.A. Li, C.Y. Ho, T.S. Lam, Y. To, W.H. Lee, M.A. Li, K.H. Chu and M. Toh. Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration. Cancer Lett. 294: 118-124, 2010.
11. Chang, C.J., C.H. Chiang, W.S. Song, S.K. Tsai, L.C. Woung, C.H. Chang, S.Y. Jeng, C.Y. Tsai, C.C. Hsu, H.F. Lee, C.S. Huang, M.C. Yung, J.H. Liu and K.H. Lu. Inhibition of phos-phorylated STAT3 by cucurbitacin I enhances chemoradiosensitivity in medulloblastoma-derived cancer stem cells. Childs Nerv. Syst. 28: 363-373, 2012.
12. Chen, J.C., M.H. Chiu, R.L. Nie, G.A. Cordell and S.X. Qiu. Cucurbitacins and cucurbitane gly-cosides: Structures and biological activities. Nat. Prod. Rep. 22: 386-399, 2005.
13. Chen, W.K., A. Leiter, D. Yin, M. Meiring, V.J. Louw and H.P. Koeffler. Cucurbitacin B inhibits growth, arrests the cell cycle, and potentiates antiproliferative efficacy of cisplatin in cutaneous squamous cell carcinoma cell lines. Int. J. Oncol. 37: 737-743, 2010a.
14. Chen, Y.W., K.H. Chen, P.I. Huang, Y.C. Chen, G.Y. Chiou, W.L. Lo, L.M. Tseng, H.S. Hsu, K.W. Chang and S.H. Chiou. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma-derived CD44()ALDH1() cells. Mol. Cancer Ther. 9: 2879-2892, 2010b.
15. Dakeng, S., S. Duangmano, W. Jiratchariyakul, Y.U. Pratya, O. Bogler and P. Patmasiriwat. Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: Reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus. J. Cell. Biochem. 113: 49-60, 2012.
16. Delhalle, S., A. Duvoix, M. Schnekenburger, F. Morceau, M. Dicato and M. Diederich. An introduction to the molecular mechanisms of apoptosis. Ann. N.Y. Acad. Sci. 1010: 1-8, 2003.
17. Duangmano, S., S. Dakeng, W. Jiratchariyakul, A. Suksamrarn, D.R. Smith and P. Patmasiriwat. Antiproliferative effects of cucurbitacin B in breast cancer cells: Down-regulation of the c-Myc/hTERT/telomerase pathway and obstruction of the cell cycle. Int. J. Mol. Sci. 11: 5323-5338, 2010.
18. Duangmano, S., P. Sae-lim, A. Suksamrarn, F.E. Domann and P. Patmasiriwat. Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation. BMC. Complem. Altern. M. 12: 185-197, 2012a.
19. Duangmano, S., P. Sae-Lim, A. Suksamrarn, P. Patmasiriwat and F.E. Domann. Cucurbitacin B causes increased radiation sensitivity of human breast cancer cells via G2/M Cell cycle arrest. J. Oncol. 2012: 601682, 2012b.
20. Elfattah, H.A., A.M. Zaghloul, A.F. Halim and E.S. Waight. Cucurbitacins and steroids from Cucumis callosus (Rottl) Cong. Acta Pharmaceut. 39: 137-141, 1989.
21. Escandell, J.M., M.C. Recio, S. Manez, R.M. Giner, M. Cerda-Nicolas and J.L. Rios. Dihy-drocucurbitacin B, isolated from Cayaponia tayuya, reduces damage in adjuvant-induced arthritis. Eur. J. Pharmacol. 532: 145-154, 2006.
22. Escandell, J.M., M.C. Recio, S. Manez, R.M. Giner, M. Cerda-Nicolas and J.L. Rios. Cucurbitacin R reduces the inflammation and bone damage associated with adjuvant arthritis in lewis rats by suppression of tumor necrosis factor-α in T lymphocytes and macrophages. J. Pharmacol. Exp. Ther. 320: 581-590, 2007.
23. Farias, M.R., E.P. Schenkel, R. Mayer and G. Rucker. Cucurbitacins as constituents of Wilbrandia ebracteata. Planta Med. 59: 272-275, 1993.
24. Feng, H., L. Zang, Z.X. Zhao and Q.C. Kan. Cucurbitacin-E inhibits multiple cancer cells proliferation through attenuation of Wnt/β-catenin signaling. Cancer Biother. Radio. 29: 210-214, 2014.
25. Fuller, R.W., J.H. Cardellina, G.M. Cragg and M.R. Boyd. Cucurbitacins: Differential cytotoxicity, dereplication and first isolation from Gonystylus keithii. J. Nat. Prod. 57: 1442-1445, 1994.
26. Galindo, A., N. Villegas and H. Mansilla. Cucurbitacins from Bryonia verrucosa: Isomerization of 2-hydroxy-3-keto-cucurbitacins. Nat. Prod. Lett. 13: 285-292, 1999.
27. Gao, Y., M.S. Islam, J. Tian, V.W. Lui and D. Xiao. Inactivation of ATP citrate lyase by Cucur-bitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth. Cancer Lett. 349: 15-25, 2014.
28. Greige-Gerges, H., R.A. Khalil, E. Abou Mansour, J. Magdalou, R. Chahine and N. Ouaini. Cucurbitacins from Ecballium elaterium juice increase the binding of bilirubin and ibuprofen to albumin in human plasma. Chem.-Bio. Interact. 169: 53-62, 2007.
29. Guo, R.H., C.A. Geng, X.Y. Huang, Y.B. Ma, Q. Zhang, L.J. Wang, X.M. Zhang, R.P. Zhang and J.J. Chen. Synthesis of hemslecin A derivatives: A new class of hepatitis B virus inhibitors. Bioorg. Med. Chem. Lett. 23: 1201-1205, 2013.
30. Gupta, P. and S.K. Srivastava. Inhibition of Integrin-HER2 signaling by cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression. Oncotarget 5: 1812-1828, 2014.
31. Halaweish, F.T. and D.W. Tallamy. Production of cucurbitacins by cucurbit cell cultures. Plant Sci. 131: 209-218, 1998.
32. Hall, A. The cytoskeleton and cancer. Cancer Metast. Rev. 28: 5-14, 2009.
33. Hassan, L.E.A., W.S. Koko, E.B.E. Osman, M.M. Dahab and H.M. Sirat. In vitro antigiardial activity of Citrullus lanatus var. citroides extracts and cucurbitacins isolated compounds. J. Med. Plants Res. 5: 3338-3346, 2011.
34. He, J., Y. Wang, L.H. Xu, J. Qiao, D.Y. Ouyang and X.H. He. Cucurbitacin IIa induces caspase-3-dependent apoptosis and enhances autophagy in lipopolysaccharide-stimulated RAW 264.7 macrophages. Int. Immunopharmacol. 16: 27-34, 2013.
35. Hsu, H.S., P.I. Huang, Y.L. Chang, C. Tzao, Y.W. Chen, H.C. Shih, S.C. Hung, Y.C. Chen, L.M. Tseng and S.H. Chiou. Cucurbitacin I inhibits tumorigenic ability and enhances radio-chemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells. Cancer 117: 2970-2985, 2011.
36. Hsu, Y.C., M.J. Chen and T.Y. Huang. Inducement of mitosis delay by cucurbitacin E: A novel tetracyclic triterpene from climbing stem of Cucumis melo L., through GADD45gamma in human brain malignant glioma (GBM) 8401 cells. Cell Death Dis. 5: e1087, 2014a.
37. Hsu, Y.C., T.Y. Huang and M.J. Chen. Therapeutic ROS targeting of GADD45gamma in the induction of G2/M arrest in primary human colorectal cancer cell lines by cucurbitacin E. Cell Death Dis. 5: e1198, 2014b.
38. Huang, W.W., J.S. Yang, M.W. Lin, P.Y. Chen, S.M. Chiou, F.S. Chueh, Y.H. Lan, S.J. Pai, M. Tsuzuki, W.J. Ho and J.G. Chung. Cucurbitacin E induces G(2)/M phase arrest through STAT3/p53/p21 signaling and provokes apoptosis via Fas/CD95 and mitochondria-dependent pathways in human bladder cancer T24 cells. Evid. Based. Complement. Alternat. Med. 2012: 952762, 2012.
39. Hung, C.M., C.C. Chang, C.W. Lin, S.Y. Ko and Y.C. Hsu. Cucurbitacin E as inducer of cell death and apoptosis in human oral squamous cell carcinoma cell line SAS. Int. J. Mol. Sci. 14: 17147-17156, 2013.
40. Ishdorj, G., J.B. Johnston and S.B. Gibson. Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B leukemic cells. BMC Cancer 11: 268-280, 2011.
41. Ishii, T., N. Kira, T. Yoshida and H. Narahara. Cucurbitacin D induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial and ovarian cancer cells. Tumor Biol. 34: 285-291, 2013.
42. Ito, A., H.B. Chai, D. Lee, L.B. Kardono, S. Riswan, N.R. Farnsworth, G.A. Cordell, J.M. Pezzuto and A.D. Kinghorn. Ellagic acid derivatives and cytotoxic cucurbitacins from Elaeocarpus mastersii. Phytochemistry 61: 171-174, 2002.
43. Iwanski, G.B., D.H. Lee, S. En-Gal, N.B. Doan, B. Castor, M. Vogt, M. Toh, C. Bokemeyer, J.W. Said, N.H. Thoennissen and H.P. Koeffler. Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer. Brt. J. Pharmacol. 160: 998-1007, 2010.
44. Jacobs, H., T. Singh, W.F. Reynolds and S. Mclean. Isolation and C-13-Nmr assignments of Cucurbitacins from Cayaponia angustiloba, Cayaponia racemosa, and Gurania subumbellata. J. Nat. Prod. 53: 1600-1605, 1990.
45. Jayaprakasam, B., N.P. Seeram and M.G. Nair. Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana. Cancer Lett. 189: 11-16, 2003.
46. Jin, H.R., X.J. Jin, N.T. Dat and J.J. Lee. Cucurbitacin B suppresses the transactivation activity of RelA/p65. J. Cell. Biochem. 112: 1643-1650, 2011a.
47. Jin, Z.S., L.M. Tian, L. Tang, G.W. Rao, Y.G. Fang and C.P. Li. Preparative isolation and purification of cucurbitacins from Pedicellus melo by high-speed counter-corrent chromatography. Chin. J. Anal. Chem. 39: 867-871, 2011b.
48. Jung, M.E. and R.M. Lui. Studies toward the total syntheses of Cucurbitacins B and D. J. Org. Chem. 75: 7146-7158, 2010.
49. Karawya, M.S., S. El-Gengaihi, M.A. Selim, H.M. Motawe and N.A. Ibrahim. Major cucurbitacins of Momordica balsamina L. Pharmazie 51: 434-435, 1996.
50. Kausar, H., R. Munagala, S.S. Bansal, F. Aqil, M.V. Vadhanam and R.C. Gupta. Cucurbitacin B potently suppresses non-small-cell lung cancer growth: Identification of intracellular thiols as critical targets. Cancer Lett. 332: 35-45, 2013.
51. Kim, H.J. and J.K. Kim. Antiangiogenic effects of cucurbitacin-I. Arch. Pharm. Res. 38(2): 290-298, 2014.
52. Kim, H.J., J.H. Park and J.K. Kim. Cucurbitacin-I, a natural cell-permeable triterpenoid isolated from Cucurbitaceae, exerts potent anticancer effect in colon cancer. Chem. Biol. Interact. 219C: 1-8, 2014.
53. Kim, S.R., H.S. Seo, H.S. Choi, S.G. Cho, Y.K. Kim, E.H. Hong, Y.C. Shin and S.G. Ko. Trichosanthes kirilowii ethanol extract and cucurbitacin D inhibit cell growth and induce apoptosis through inhibition of STAT3 activity in breast cancer cells. Evid. Based Complement. Alt. 2013: 975350, 2013.
54. Kumar, N.S. and G. Madhurambal. Effect of Cucurbitacin L on the crystal defects of cholesterol monohydrate. Asian J. Chem. 23: 1401-1402, 2011.
55. Kupchan, S.M., R.M. Smith, Y. Aynehchi and M. Maruyama. Tumor inhibitors. LVI. Cucurbitacins O, P, and Q, the cytotoxic principles of Brandegea bigelovii. J. Org. Chem. 35: 2891-2894, 1970.
56. Lan, T., L. Wang, Q. Xu, W. Liu, H. Jin, W. Mao, X. Wang and X. Wang. Growth inhibitory effect of Cucurbitacin E on breast cancer cells. Int. J. Clin. Exp. Patho. 6: 1799-1805, 2013.
57. Lang, K.L., I.T. Silva, L.A. Zimmermann, V.R. Machado, M.R. Teixeira, M.I. Lapuh, M.A. Galetti, J.A. Palermo, G.M. Cabrera, L.S. Bernardes, C.M. Simoes, E.P. Schenkel, M.S. Caro and F.J. Duran. Synthesis and cytotoxic activity evaluation of dihydrocucurbitacin B and cucurbitacin B derivatives. Bioorg. Med. Chem. 20: 3016-3030, 2012.
58. Lee, D.H., G.B. Iwanski and N.H. Thoennissen. Cucurbitacin: Ancient compound shedding new light on cancer treatment. The Scientific World J. 10: 413-418, 2010.
59. Lee, D.H., N.H. Thoennissen, C. Goff, G.B. Iwanski, C. Forscher, N.B. Doan, J.W. Said and H.P. Koeffler. Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma. Cancer Lett. 306: 161-170, 2011.
60. Li, J.J., Y.T. Zhang, D.Y. Ouyang, L.H. Xu, H.B. Mo and X.H. He. Suppression of STAT3 phos-phorylation enhances the cytotoxicity of cucurbitacin B in B16F10 melanoma cells. Afr. J. Pharm. Pharmaco. 6: 1545-1554, 2012.
61. Liu, T.Y., H.G. Peng, M.X. Zhang, Y.H. Deng and Z.H. Wu. Cucurbitacin B, a small molecule inhibitor of the STAT3 signaling pathway, enhances the chemosensitivity of laryngeal squa-mous cell carcinoma cells to cisplatin. Eur. J. Pharmacol. 641: 15-22, 2010.
62. Liu, T.Y., M.X. Zhang, H.L. Zhang, C.Y. Sun and Y.H. Deng. Inhibitory effects of cucurbitacin B on laryngeal squamous cell carcinoma. Eur. Arch. Oto-Rhino-L. 265: 1225-1232, 2008.
63. Lopez-Haber, C. and M.G. Kazanietz. Cucurbitacin I inhibits Rac1 activation in breast cancer cells by a reactive oxygen species-mediated mechanism and independently of Janus tyrosine kinase 2 and P-Rex1. Mol. Pharmacol. 83: 1141-1154, 2013.
64. Lu, P., B.D. Yu and J. Xu. Cucurbitacin B regulates immature myeloid cell differentiation and enhances antitumor immunity in patients with lung cancer. Cancer Biother. Radio. 27: 495-503, 2012.
65. Lui, V.W., D.M. Yau, E.Y. Wong, Y.K. Ng, C.P. Lau, Y. Ho, J.P. Chan, B. Hong, K. Ho, C.S. Cheung, C.M. Tsang, S.W. Tsao and A.T. Chan. Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells. Carcinogenesis 30: 2085-2094, 2009.
66. Mai, L.P., D. Guenard, M. Franck, M. Van Tri, C. Gaspard and T. Sevenet. New cytotoxic cucur-bitacins from the pericarps of Trichosanthes tricuspidata fruits. Nat. Prod. Lett. 16: 15-19, 2002.
67. Maloney, K.N., M. Fujita, U.S. Eggert, F.C. Schroeder, C.M. Field, T.J. Mitchison and J. Clardy. Actin-aggregating cucurbitacins from Physocarpus capitatus. J. Nat. Prod. 71: 1927-1929, 2008.
68. Mei, W.L., F. Lin, W.J. Zuo, H. Wang and H.F. Dai. Cucurbitacins from fruits of Aquilaria sinensis. Chin. J. Nat. Med. 10: 234-237, 2012.
69. Metcalf, R.L., R.A. Metcalf and A.M. Rhodes. Cucurbitacins as kairomones for diabroticite beetles. Proc. Natl. Acad. Sci. USA. 77: 3769-3772, 1980.
70. Miro, M. Cucurbitacins and their pharmacological effects. Phytother. Res. 9: 159-168, 1995.
71. Molavi, O., Z.S. Ma, A. Mahmud, A. Alshamsan, J. Samuel, R. Lai, G.S. Kwon and A. Lavasanifar. Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors. Int. J. Pharm. 347: 118-127, 2008.
72. Musza, L.L., P. Speight, S. Mcelhiney, C.J. Barrow, A.M. Gillum, R. Cooper and L.M. Killar. Cucurbitacins, cell-adhesion inhibitors from Conobea scoparioides. J. Nat. Prod. 57: 1498-1502, 1994.
73. Nayab, D., D. Ali, N. Arshad, A. Malik, M.I. Choudhary and Z. Ahmed. Cucurbitacin glucosides from Citrullus colocynthis. Nat. Prod. Res. 20: 409-413, 2006.
74. Oh, H., Y.J. Mun, S.J. Im, S.Y. Lee, H.J. Song, H.S. Lee and W.H. Woo. Cucurbitacins from Trichosanthes kirilowii as the inhibitory components on tyrosinase activity and melanin synthesis of B16/F10 melanoma cells. Planta Med. 68: 832-833, 2002.
75. Ouyang, D.Y., Y.T. Zhang, L.H. Xu, J.J. Li, Q.B. Zha and X.H. He. Histone deacetylase inhibitor valproic acid sensitizes B16F10 melanoma cells to cucurbitacin B treatment. Acta Bioch. Bioph. Sin. 43: 487-495, 2011.
76. Panosian, A.G., M.A. Dadaian and E.S. Gabrielian. Cucurbitacin R glycoside - A regulator of steroidogenesis and of the formation of prostaglandin E2 - A specific modulator of the hypothalamus-hypophysis-adrenal cortex system. Biull. Eksp. Biol. Med. 104: 456-457, 1987.
77. Panosyan, A.G. Influence of Cucurbitacins of Bryonia-Alba L on the biosynthesis of eicosanoids in human-leukocytes. Russ. J. Bioorg. Chem. 11: 264-269, 1985.
78. Promkan, M., S. Dakeng, S. Chakrabarty, O. Bogler and P. Patmasiriwat. The effectiveness of Cucurbitacin B in BRCA1 defective breast cancer cells. Plos One 8: e55732, 2013.
79. Qing, Z.X., Y. Zhou, X.B. Liu, P. Cheng and J.G. Zeng. 23, 24-Dihydrocucurbitacin C: A new compound regarded as the next metabolite of cucurbitacin C. Nat. Prod. Res. 28: 1165-1170, 2014.
80. Recio, M.C., M. Prieto, M. Bonucelli, C. Orsi, S. Manez, R.M. Giner, M. Cerda-Nicolas and J.L. Rios. Anti-inflammatory activity of two cucurbitacins isolated from Cayaponia tayuya roots. Planta Med. 70: 414-420, 2004.
81. Ren, S., D.Y. Ouyang, M. Saltis, L.H. Xu, Q.B. Zha, J.Y. Cai and X.H. He. Anti-proliferative effect of 23, 24-dihydrocucurbitacin F on human prostate cancer cells through induction of actin aggregation and cofilin-actin rod formation. Cancer Chemoth. Pharm. 70: 415-424, 2012.
82. Saade, M., J. Magdalou, N. Ouaini and H. Greige-Gerges. Stability of cucurbitacin E in human plasma: Chemical hydrolysis and role of plasma esterases. Biopharm. Drug Dispos. 30: 389-397, 2009.
83. Sadzuka, Y., H. Hatakeyama and T. Sonobe. Enhancement of doxorubicin concentration in the M5076 ovarian sarcoma cells by cucurbitacin E co-treatment. Int. J. Pharm. 383: 186-191, 2010.
84. Sallam, A.A., Y. Hitotsuyanagi, E.S.S. Mansour, A.F. Ahmed, S. Gedara, H. Fukaya and K. Takeya. Cucurbitacins from Bryonia cretica. Phytochem. Lett. 3: 117-121, 2010.
85. Sarker, S.D., P. Whiting, V. Sik and L. Dinan. Ecdysteroid antagonists (cucurbitacins) from Phy-socarpus opulifolius (Rosaceae). Phytochemistry 50: 1123-1128, 1999.
86. Seger, C., S. Sturm, E. Haslinger and H. Stuppner. NMR signal assignment of 22-deoxocucurbitacin D and Cucurbitacin D from Ecballium elaterium L. (Cucurbitaceae). Monatsh. Chem. 136: 1645-1649, 2005.
87. Seo, C.R., D.K. Yang, N.J. Song, U.J. Yun, A.R. Gwon, D.G. Jo, J.Y. Cho, K. Yoon, J.Y. Ahn, C.W. Nho, W.J. Park, S.Y. Yang and K.W. Park. Cucurbitacin B and cucurbitacin I suppress adipocyte differentiation through inhibition of STAT3 signaling. Food Chem. Toxicol. 64: 217-224, 2014.
88. Shan, X.L., X.Y. Zhou, J. Yang, Y.L. Wang, Y.H. Deng and M.X. Zhang. Inhibitory effect of cucurbitacin E on the proliferation of ovarian cancer cells and its mechanism. Chin. J. Cancer 29: 20-24, 2010.
89. Sherr, C.J. The pezcoller lecture: Cancer cell cycles revisited. Cancer Res. 60: 3689-3695, 2000.
90. Shi, X., B. Franko, C. Frantz, H.M. Amin and R. Lai. JSI-124 (cucurbitacin I) inhibits Janus kinase-3/signal transducer and activator of transcription-3 signalling, downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cells. Brit. J. Haematol. 135: 26-32, 2006.
91. Shohat, B., S. Gitter and D. Lavie. Antitumor activity of cucurbitacins: Metabolic aspects. Cancer Chemother. Rep. 23: 19-24, 1962.
92. Spear, S.A., S.S. Burns, J.L. Oblinger, Y. Ren, L. Pan, A.D. Kinghorn, D.B. Welling and L.S. Chang. Natural compounds as potential treatments of NF2-deficient schwannoma and meningioma: Cucurbitacin D and goyazensolide. Otol. Neurotol. 34: 1519-1527, 2013.
93. Stuppner, H. and E.P. Muller. Cucurbitacins with unusual side-chains from Picrorhiza kurroa. Phytochemistry 33: 1139-1145, 1993.
94. Sturm, S. and H. Stuppner. Analysis of cucurbitacins in medicinal plants by high-pressure liquid chromatography-mass spectrometry. Phytochem. Anal. 11: 121-127, 2000.
95. Sun, C., M. Zhang, X. Shan, X. Zhou, J. Yang, Y. Wang, J. Li-Ling and Y. Deng. Inhibitory effect of cucurbitacin E on pancreatic cancer cells growth via STAT3 signaling. J. Cancer Res. Clin. 136: 603-610, 2010.
96. Sun, J., M.A. Blaskovich, R. Jove, S.K. Livingston, D. Coppola and S.M. Sebti. Cucurbitacin Q: A selective STAT3 activation inhibitor with potent antitumor activity. Oncogene 24: 3236-3245, 2005.
97. Takahashi, N., Y. Yoshida, T. Sugiura, K. Matsuno, A. Fujino and U. Yamashita. Cucurbitacin D isolated from Trichosanthes kirilowii induces apoptosis in human hepatocellular carcinoma cells in vitro. Int. Immunopharmacol. 9: 508-513, 2009.
98. Tannin-Spitz, T., S. Grossman, S. Dovrat, H.E. Gottlieb and M. Bergman. Growth inhibitory activity of cucurbitacin glucosides isolated from Citrullus colocynthis on human breast cancer cells. Biochem. Pharmacol. 73: 56-67, 2007.
99. Thoennissen, N.H., G.B. Iwanski, N.B. Doan, R. Okamoto, P. Lin, S. Abbassi, J.H. Song, D. Yin, M. Toh, W.D. Xie, J.W. Said and H.P. Koeffler. Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells. Cancer Res. 69: 5876-5884, 2009.
100. Tseng, L.M., P.I. Huang, Y.R. Chen, Y.C. Chen, Y.C. Chou, Y.W. Chen, Y.L. Chang, H.S. Hsu, Y.T. Lan, K.H. Chen, C.W. Chi, S.H. Chiou, D.M. Yang and C.H. Lee. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133 cells. J. Pharmacol. Exp. Ther. 341: 410-423, 2012.
101. U-Pratya, Y., U. Lueangamornnara, W. Jiratchariyakul and T. Kummalue. Immunosuppressive effects of cucurbitacin B on human peripheral blood lymphocytes. J. Med. Plants Res. 4: 2340-2347, 2010.
102. van Kester, M.S., J.J. Out-Luiting, P.A. von dem Borne, R. Willemze, C.P. Tensen and M.H. Vermeer. Cucurbitacin I inhibits Stat3 and induces apoptosis in Sezary cells. J. Invest. Dermatol. 128: 1691-1695, 2008.
103. Wu, P.L., F.W. Lin, T.S. Wu, C.S. Kuoh, K.H. Lee and S.J. Lee. Cytotoxic and anti-HIV principles from the rhizomes of Begonia nantoensis. Chem. Pharm. Bull. 52: 345-349, 2004.
104. Xu, G.W. and Y.F. Shi. Apoptosis signaling pathways and lymphocyte homeostasis. Cell Res. 17: 759-771, 2007.
105. Xu, X.T., Z.P. Deng, H.X. Fan, H. Zhong and Q.Q. Yao. Study on in vivo pharmacokinetics of cucurbitacin injection in rats. Zhongguo Zhong Yao Za Zhi 39: 2126-2130, 2014.
106. Yang, K., Y. Wen and C. Wang. Clinical application of anticancer nanoparticles targeting metastasis foci of cervical lymph nodes in patients with oral carcinoma. Hua Xi Kou Qiang Yi Xue Za Zhi 21: 447-450, 2003.
107. Yasuda, S., S. Yogosawa, Y. Izutani, Y. Nakamura, H. Watanabe and T. Sakai. Cucurbitacin B induces G(2) arrest and apoptosis via a reactive oxygen species-dependent mechanism in human colon adenocarcinoma SW480 cells. Mol. Nutr Food Res. 54: 559-565, 2010.
108. Yin, D., N. Wakimoto, H.T. Xing, D.N. Lu, T. Huynh, X. Wang, K.L. Black and H.P. Koeffler. Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme. Int. J. Cancer. 123: 1364-1375, 2008.
109. Yuan, G., S.F. Yan, H. Xue, P. Zhang, J.T. Sun and G. Li. Cucurbitacin I induces protective autophagy in glioblastoma in vitro and in vivo. J. Biol. Chem. 289: 10607-10619, 2014.
110. Zhang, M.X., H.L. Zhang, C.Y. Sun, X.L. Shan, X.L. Yang, J. Li-Ling and Y.H. Deng. Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepato-cellular carcinoma cells by cucurbitacin B. Cancer Chemother. Pharmcol. 63: 635-642, 2009.
111. Zhang, T., J. Li, Y. Dong, D. Zhai, L. Lai, F. Dai, H. Deng, Y. Chen, M. Liu and Z. Yi. Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion. Breast Cancer Res. Tr. 135: 445-458, 2012a.
112. Zhang, T., Y. Li, K.A. Park, H.S. Byun, M. Won, J. Jeon, Y. Lee, J.H. Seok, S.W. Choi, S.H. Lee, J. Man Kim, J.H. Lee, C.G. Son, Z.W. Lee, H.M. Shen and G.M. Hur. Cucurbitacin induces autophagy through mitochondrial ROS production which counteracts to limit caspase-dependent apoptosis. Autophagy. 8: 559-576, 2012b.
113. Zhang, Y.T., D.Y. Ouyang, L.H. Xu, Y.H. Ji, Q.B. Zha, J.Y. Cai and X.H. He. Cucurbitacin B induces rapid depletion of the G-actin pool through reactive oxygen species-dependent actin aggregation in melanoma cells. Acta Biochim. Biophy. Sin. 43: 556-567, 2011.
114. Zhang, Y.T., D.Y. Ouyang, L.H. Xu, Q.B. Zha and X.H. He. Formation of cofilin-actin rods following cucurbitacin-B-induced actin aggregation depends on slingshot homolog 1-mediated cofilin hyperactivation. J. Cell. Biochem. 114: 2415-2429, 2013.
115. Zheng, Q., Y. Liu, W. Liu, F. Ma, Y. Zhou, M. Chen, J. Chang, Y. Wang, G. Yang and G. He. Cucurbitacin B inhibits growth and induces apoptosis through the JAK2/STAT3 and MAPK pathways in SH-SY5Y human neuroblastoma cells. Mol. Med. Rep. 10: 89-94, 2014.
116. Zhou, X.Y., J. Yang, Y.L. Wang, W. Li, J. Li-Ling, Y.H. Deng and M.X. Zhang. Cucurbitacin B inhibits 12-O-tetradecanoylphorbol 13-acetate-induced invasion and migration of human hepatoma cells through inactivating mitogen-activated protein kinase and PI3K/Akt signal transduction pathways. Hepatol. Res. 42: 401-411, 2012.